Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov 7;17(10):709-716.
doi: 10.18502/ijrm.v17i10.5287. eCollection 2019 Oct.

Artificial colloids versus human albumin for the treatment of ovarian hyperstimulation syndrome: A retrospective cohort study

Tetsuji Minami  1   2 , Mph  1   2   3 , Hayato Yamana  1 , Mph Ph D  1   2   3 , Daisuke Shigemi  1 , Mph  1   2   3 , Hiroki Matsui Mph  1   2   3 , Kiyohide Fushimi  2 , Ph D  1   2   3 , Hideo Yasunaga  1 , Ph D  1   2   3
Affiliations

Artificial colloids versus human albumin for the treatment of ovarian hyperstimulation syndrome: A retrospective cohort study

Tetsuji Minami et al. Int J Reprod Biomed. .

Abstract

Background: The optimal colloid solution for the treatment of ovarian hyperstimulation syndrome (OHSS) remains to be established.

Objective: We aimed to compare artificial colloids (AC) with human albumin (HA) for the treatment of OHSS.

Materials and methods: In this retrospective cohort study, data for OHSS participants were collected from a national inpatient database in Japan. The participants received intravenous fluid management with AC (n = 156) or HA (n = 127). We compared the two groups in terms of the length of stay, development of post-treatment complications, and termination surgery.

Results: In multivariable linear regression analyses for log-transformed length of stay with reference to the OHSS participants receiving AC, the regression coefficient (95% confidence interval) in participants receiving HA was 0.03 (-0.04-0.09, p = 0.42). Thromboembolism occurred in two participants in the HA group and three participants in the AC group. Two participants in the HA group suffered renal failure during hospitalization. No participants underwent termination surgery in the two groups.

Conclusion: The present results showed comparable efficacy between AC and HA for the treatment of OHSS. There were no significant differences in post-treatment complications between the two groups.

Keywords: Colloid; Length of stay.; Treatment; Ovarian hyperstimulation syndrome.

PubMed Disclaimer

Conflict of interest statement

No conflicts of interest are disclosed.

References

    1. Garcia-Velasco J. A., Pellicer A. New concepts in the understanding of the ovarian hyperstimulation syndrome. Current Opinion in Obstetrics and Gynecology. 2003;15(3):251–256. doi: 10.1097/00001703-200306000-00007. - DOI - PubMed
    1. Kwik M., Maxwell E. Pathophysiology, treatment and prevention of ovarian hyperstimulation syndrome. Current Opinion in Obstetrics and Gynecology. 2016;28(4):236–241. doi: 10.1097/GCO.0000000000000284. - DOI - PubMed
    1. Borase H., Mathur R. Ovarian hyperstimulation syndrome: Clinical features, prevention and management. Obstetrics, Gynaecology and Reproductive Medicine . 2012;22(7):186–190. doi: 10.1016/j.ogrm.2012.03.003. - DOI
    1. Chen C., Chen S., Yang Y. Prevention and management of ovarian hyperstimulation syndrome. Best Practice & Research Clinical Obstetrics & Gynaecology. 2012;26(6):817–827. doi: 10.1016/j.bpobgyn.2012.04.004. - DOI - PubMed
    1. Abramov Y., Fatum M., Abrahamov D., Schenker J. G. Hydroxyethylstarch versus human albumin for the treatment of severe ovarian hyperstimulation syndrome: a preliminary report. Fertility and Sterility. 2001;75(6):1228–1230. doi: 10.1016/S0015-0282(01)01784-8. - DOI - PubMed

LinkOut - more resources